This report contains market size and forecasts of Risedronate Sodium API in global, including the following market information:
Global Risedronate Sodium API Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Risedronate Sodium API Market Sales, 2017-2022, 2023-2028, (Tons)
Global top five Risedronate Sodium API companies in 2021 (%)
The global Risedronate Sodium API market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Purity ≥99% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Risedronate Sodium API include Ind-Swift Laboratories, Jubilant Pharma, Pharmaffiliates, Teva, Heer Pharma, Tianfeng Fine Chemical, Topfond Pharmaceutical, Tongxiang Hengda Chemical and Yangtze River Pharmaceutical Group and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Risedronate Sodium API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Risedronate Sodium API Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Risedronate Sodium API Market Segment Percentages, by Type, 2021 (%)
Purity ≥99%
Purity ≥99.5%
Global Risedronate Sodium API Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Risedronate Sodium API Market Segment Percentages, by Application, 2021 (%)
Tablet
Capsule
Global Risedronate Sodium API Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Risedronate Sodium API Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Risedronate Sodium API revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Risedronate Sodium API revenues share in global market, 2021 (%)
Key companies Risedronate Sodium API sales in global market, 2017-2022 (Estimated), (Tons)
Key companies Risedronate Sodium API sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Ind-Swift Laboratories
Jubilant Pharma
Pharmaffiliates
Teva
Heer Pharma
Tianfeng Fine Chemical
Topfond Pharmaceutical
Tongxiang Hengda Chemical
Yangtze River Pharmaceutical Group
Jiangyin Chengye Chemical